Investigation of the association between ten pathogens causing sexually transmitted diseases and high-risk human papilloma virus infection in Shanghai

被引:22
作者
Xie, Li [1 ]
Li, Qian [1 ]
Dong, Xiangrong [2 ]
Kong, Qi [3 ]
Duan, Yuping [1 ]
Chen, Xiong [1 ]
Li, Xiaoqiang [1 ]
Hong, Mao [1 ]
Liu, Tao [1 ]
机构
[1] Fudan Univ, Wusong Hosp, Zhongshan Hosp, Clin Lab, 101 Tong Tai North Rd, Shanghai 200940, Peoples R China
[2] Shanghai Gongli Hosp, Ear Nose & Throat Dept, Shanghai 200940, Peoples R China
[3] South China Univ Technol, Sch Biol & Biol Engn, Guangzhou 510641, Guangdong, Peoples R China
关键词
STDs; HPV; TCT; CIN; UREAPLASMA-UREALYTICUM; WOMEN;
D O I
10.3892/mco.2021.2294
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cervical cancer, one of the high-incidence female malignant tumors, has predominated in recent years. Persistent infection with high-risk human papillomavirus (HR-HPV) is the main cause of cervical cancer. Studies have shown that infection with certain sexually transmitted disease (STD) pathogens increases the risk of persistent infection with HR-HPV and is a high-risk factor for cervical cancer. In the present study, cervical specimens were collected for Thinprep cytology test detection, while DNA of cervical cells was extracted for HPV genotyping and detection of 10 STD pathogens, including Neisseria gonorrhoeae, Chlamydia trachomatis (CT), Ureaplasma urealyticum, Ureaplasma urealyticum parvum (Uup)1, Uup3, Uup6, Uup14, Mycoplasma hominis (Mh), Mycoplasma genitalium (Mg) and herpes simplex virus II. Significant differences were observed between CT, Mh and Mg infections and HR-HPV infection (P<0.05). In addition, CT, Uup3, Uup6 and Mh infections were associated with HR-HPV infection (odds ratio >1; P<0.05). In the comparison of Uup3, Uup6 and Mg infections between the cervical intraepithelial neoplasia (CIN) group and the control group, statistically significant differences were observed (P<0.05). In conclusion, the incidences of CT, Mh and Mg infections were similar with HR-HPV infection. CT, Uup6, Mh and Mg infections were risk factors for HR-HPV infection. Finally, Uup3, Uup6 and Mg were risk factors of CIN.
引用
收藏
页数:7
相关论文
共 30 条
[1]   Concomitant infections with human papillomavirus and various mycoplasma and ureaplasma species in women with abnormal cervical cytology [J].
Biernat-Sudolska, M. ;
Szostek, S. ;
Rojek-Zakrzewska, D. ;
Klimek, M. ;
Kosz-Vnenchak, M. .
ADVANCES IN MEDICAL SCIENCES, 2011, 56 (02) :299-303
[2]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[3]   Updated medical care cost estimates for HPV-associated cancers: implications for cost-effectiveness analyses of HPV vaccination in the United States [J].
Chesson, Harrell W. ;
Meites, Elissa ;
Ekwueme, Donatus U. ;
Saraiya, Mona ;
Markowitz, Lauri E. .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (7-8) :1942-1948
[4]  
Deguchi Takashi, 2009, Nihon Rinsho, V67, P167
[5]   Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV+ Cancers [J].
Galliverti, Gabriele ;
Wullschleger, Stephan ;
Tichet, Melanie ;
Murugan, Dhaarini ;
Zangger, Nadine ;
Horton, Wesley ;
Korman, Alan J. ;
Coussens, Lisa M. ;
Swartz, Melody A. ;
Hanahan, Douglas .
CANCER IMMUNOLOGY RESEARCH, 2020, 8 (01) :131-145
[6]  
Grattard F, 1995, MOL CELL PROBE, V9, P383
[7]  
Hajia Massoud, 2018, Asian Pac J Cancer Prev, V19, P785, DOI 10.22034/APJCP.2018.19.3.785
[8]   Joint effect of HPV16 with Chlamydia trachomatis and smoking on risk of cervical cancer:: antagonism or misclassification (Nordic countries) [J].
Hakama, M ;
Luostarinen, T ;
Hallmans, G ;
Jellum, E ;
Koskela, P ;
Lehtinen, M ;
Thoresen, S ;
Youngman, L ;
Hakulinen, T .
CANCER CAUSES & CONTROL, 2000, 11 (09) :783-790
[9]   STI update: Testing, treatment, and emerging threats [J].
Hlatshwayo, Matifadza ;
Reno, Hilary E. L. ;
Yarbrough, Melanie L. .
CLEVELAND CLINIC JOURNAL OF MEDICINE, 2019, 86 (11) :733-740
[10]   Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women? - a position statement from the European STI Guidelines Editorial Board [J].
Horner, P. ;
Donders, G. ;
Cusini, M. ;
Gomberg, M. ;
Jensen, J. S. ;
Unemo, M. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (11) :1845-1851